The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics.
WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version.
The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal.
WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%.
Barcelona to get floating desalination plant to help fight drought in northeastern Spain
Publican pleads guilty to stealing $180,000 in grant funding
Bill to remove Easter alcohol restrictions drawn from ballot
Caitlin Clark and Angel Reese are OVERPAID at $75k
Brazil’s Central Bank reduces basic interest rate to 11.25% per year
China sanctions 2 US defense companies and says they support arms sales to Taiwan
Shooting at Ramadan event in West Philadelphia leaves 3 injured, 5 in custody, police say
Zimbabwe frees prisoners, including those sentenced to death, in an independence day amnesty
Four children among seven injured in Northland crash as police seek witnesses
Prince Harry confirms he is now a US resident
Activist on trial in secret in China for saying Xi Jinping 'not smart enough'